Skip to main content

Showing 1–5 of 5 results for author: King, I

Searching in archive q-bio. Search in all archives.
.
  1. arXiv:2402.04286  [pdf

    q-bio.QM cs.AI cs.LG

    Progress and Opportunities of Foundation Models in Bioinformatics

    Authors: Qing Li, Zhihang Hu, Yixuan Wang, Lei Li, Yimin Fan, Irwin King, Le Song, Yu Li

    Abstract: Bioinformatics has witnessed a paradigm shift with the increasing integration of artificial intelligence (AI), particularly through the adoption of foundation models (FMs). These AI techniques have rapidly advanced, addressing historical challenges in bioinformatics such as the scarcity of annotated data and the presence of data noise. FMs are particularly adept at handling large-scale, unlabeled… ▽ More

    Submitted 5 February, 2024; originally announced February 2024.

    Comments: 27 pages, 3 figures, 2 tables

    MSC Class: cs.CL; 92-02 ACM Class: I.2.1

  2. arXiv:2306.15890  [pdf, other

    cs.LG physics.chem-ph q-bio.QM

    A Unified View of Deep Learning for Reaction and Retrosynthesis Prediction: Current Status and Future Challenges

    Authors: Ziqiao Meng, Peilin Zhao, Yang Yu, Irwin King

    Abstract: Reaction and retrosynthesis prediction are fundamental tasks in computational chemistry that have recently garnered attention from both the machine learning and drug discovery communities. Various deep learning approaches have been proposed to tackle these problems, and some have achieved initial success. In this survey, we conduct a comprehensive investigation of advanced deep learning-based mode… ▽ More

    Submitted 27 June, 2023; originally announced June 2023.

    Comments: Accepted as IJCAI 2023 Survey

  3. arXiv:2301.05931  [pdf, other

    cs.LG q-bio.QM

    Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

    Authors: Zhihang Hu, Qinze Yu, Yucheng Guo, Taifeng Wang, Irwin King, Xin Gao, Le Song, Yu Li

    Abstract: Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. However, identifying novel drug combinations through wet-lab experiments is resource intensive due to the vast combinatorial search space. Recently, computational approaches, specifically deep learning models have emerged as an efficient way to discover synergistic c… ▽ More

    Submitted 14 January, 2023; originally announced January 2023.

  4. arXiv:2207.01586  [pdf, other

    q-bio.QM cs.LG q-bio.BM

    E2Efold-3D: End-to-End Deep Learning Method for accurate de novo RNA 3D Structure Prediction

    Authors: Tao Shen, Zhihang Hu, Zhangzhi Peng, Jiayang Chen, Peng Xiong, Liang Hong, Liangzhen Zheng, Yixuan Wang, Irwin King, Sheng Wang, Siqi Sun, Yu Li

    Abstract: RNA structure determination and prediction can promote RNA-targeted drug development and engineerable synthetic elements design. But due to the intrinsic structural flexibility of RNAs, all the three mainstream structure determination methods (X-ray crystallography, NMR, and Cryo-EM) encounter challenges when resolving the RNA structures, which leads to the scarcity of the resolved RNA structures.… ▽ More

    Submitted 4 July, 2022; originally announced July 2022.

  5. arXiv:2204.00300  [pdf, other

    q-bio.QM

    Interpretable RNA Foundation Model from Unannotated Data for Highly Accurate RNA Structure and Function Predictions

    Authors: Jiayang Chen, Zhihang Hu, Siqi Sun, Qingxiong Tan, Yixuan Wang, Qinze Yu, Licheng Zong, Liang Hong, ** Xiao, Tao Shen, Irwin King, Yu Li

    Abstract: Non-coding RNA structure and function are essential to understanding various biological processes, such as cell signaling, gene expression, and post-transcriptional regulations. These are all among the core problems in the RNA field. With the rapid growth of sequencing technology, we have accumulated a massive amount of unannotated RNA sequences. On the other hand, expensive experimental observato… ▽ More

    Submitted 7 August, 2022; v1 submitted 1 April, 2022; originally announced April 2022.